Pharmacist Letter: June 2016; Vol: 32, No. 6
Are you a pharmacist interested in adding to your education and knowledge about the latest developments in drug therapy, but hate wasting time? Then we are sure you will love Pharmacist's Letter for its concise, practical information.
In search for online readings for your CPE points? Pharmacist’s Letter is also a recognized online CPE provider by the Singapore Pharmacy Council! Each reading is worth 1 CPE point. So start reading now!
Log into the PSS website with your membership number and password to access Pharmacist’s Letter now! Here are the interesting topics for the month of June 2016
What’s New on Pharmacist Letter: June 2016; Vol: 32, No. 6
Topic of the month: Appropriate Use of Metformin in Patients with Kidney Disease
Many patients who may benefit from the Metformin do not receive it due to concerns of high risk of lactic acidosis, especially in patients with renal failure. However, recent evidence suggests that some of these patients can safely receive metformin therapy, especially those with mild to moderate renal dysfunction. Based on this evidence, the FDA is requiring labelling changes in the prescribing information for metformin-containing products. Listen to what the PL team has to say about use of Metformin in special populations.
Clinical updates:
- Antiplatelet therapy is often used in patients with coronary artery disease (CAD). It can be difficult to remember for which indications dual antiplatelet therapy is recommended, and for how long it should be continued. Check out the PL chart based largely on the 2016 ACC/AHA guideline on the option and duration of dual antiplatelet therapy in patients with coronary artery disease.
- The overall incidence of antibiotic-associated CNS adverse effects is often reported as 1%, but it may be underdiagnosed, perhaps because of the myriad other potential causes of CNS. Find out which are the antibiotics for which central nervous system adverse effects are relatively common in this PL article.
Frequently asked questions at the community pharmacy:
- I am pregnant and suspected to be having a yeast infection, what should I do?
The U.S. Food and Drug Administration (FDA) is evaluating the results of a Danish study that conclude there is a possible increased risk of miscarriage with the use of oral fluconazole (Diflucan) for yeast infections. Be aware of the latest treatment guidelines for Candidiasis from the Infectious Disease Society of America.
2) Ouch! I am in pain. Help me!
Do you know what are the topical pharmacologic options and natural remedies for the treatment of pain? Learn about it here in this PL article.
